In 2016, the U.S. Nuclear Regulatory Commission (NRC) issued the SHINE construction permit. SHINE is the only U.S. medical isotope producer to have reached this stage of the NRC permitting process since the 1960s.
The issuance of the construction permit was the culmination of more than four years of effort by both SHINE and the NRC. It follows two years of environmental data collection and safety analysis by SHINE, as well as two years of rigorous safety and environmental reviews by the NRC.
With the construction permit in hand, SHINE has federal regulatory approval to begin construction of its approximately 57,000 ft² medical isotope manufacturing facility in Janesville, WI.
It was the first time in over fifty years a medical isotope plant of this kind was granted a construction permit.